Loading...
XTAI
1701
Market cap211mUSD
Aug 20, Last price  
21.15TWD
Name

China Chemical & Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XTAI:1701 chart
P/E
19.56
P/S
0.74
EPS
1.08
Div Yield, %
—
Shrs. gr., 5y
0.09%
Rev. gr., 5y
2.50%
Revenues
8.57b
+1.40%
4,353,831,0004,555,141,0005,024,675,0004,947,571,0005,173,846,0005,297,426,0005,627,644,0005,781,413,0006,244,807,0007,580,236,0007,969,700,0008,181,056,0007,948,998,0008,456,512,0008,574,719,999
Net income
322m
-32.51%
387,913,000358,416,000305,904,000322,118,000240,347,000347,723,000353,696,000313,209,000310,739,000369,870,000384,690,000557,365,000517,508,000477,541,000322,294,000
CFO
239m
+43.10%
447,612,000377,266,000114,851,000365,259,000402,583,000330,409,000554,847,000194,220,000462,305,000152,926,000327,513,000897,071,000695,891,000167,272,000239,365,000
Dividend
Jul 26, 20240.50003 TWD/sh
Earnings
Aug 04, 2025

Profile

China Chemical & Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals. The company provides sexual function supplements; cardiovascular drugs, anti-lipidemia drugs, and peripheral circulation impediment relieving agents; diabetes treatment drugs, adrenocortico steroids, and weight control drugs; and anti-infection drugs, such as antibiotics, antifungal drugs, and anti-viral drugs. It also offers nutritional supplements comprising vitamins, liver toning agents, and electrolyte and calorie preparations; antipyretic, analgesic, and anti-inflammatory medicines; digestive drugs, intestinal improvement agents, and antispasmodics; cough suppressants, antihistamines, and asthma treatment agents; BPH drugs for the urinary system; hypnotic, mental stability, and antidepressant drugs; hematology/oncology drugs; and other general preparations. In addition, the company provides over the counter drugs such as vitamins, external skin care products, cold and cough medicines, anti-inflammatory analgesics, and gastrointestinal drugs; and antibacterial and disinfection medicines. Further, it manufactures animal health products, including drugs for pigs and cattle, companion animal products, poultry drugs, and feed supplements; and offers contract manufacturing services. The company was founded in 1952 and is headquartered in Taipei, Taiwan.
URL
http://www.ccpc.com.tw/
IPO date
Feb 09, 1962
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
8,574,720
1.40%
8,456,512
6.38%
Cost of revenue
8,437,054
8,087,740
Unusual Expense (Income)
NOPBT
137,666
368,772
NOPBT Margin
1.61%
4.36%
Operating Taxes
67,644
109,402
Tax Rate
49.14%
29.67%
NOPAT
70,022
259,370
Net income
322,294
-32.51%
477,541
-7.72%
Dividends
(238,465)
(268,273)
Dividend yield
3.28%
2.69%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
1,688,034
1,351,809
Long-term debt
2,065,668
1,912,130
Deferred revenue
313,584
Other long-term liabilities
98,598
105,392
Net debt
961,779
651,379
Cash flow
Cash from operating activities
239,365
167,272
CAPEX
(306,061)
(270,974)
Cash from investing activities
(332,436)
(374,611)
Cash from financing activities
(247,143)
(209,400)
FCF
(502,717)
94,265
Balance
Cash
489,218
852,264
Long term investments
2,302,705
1,760,296
Excess cash
2,363,187
2,189,734
Stockholders' equity
6,852,209
6,810,004
Invested Capital
8,598,013
8,422,435
ROIC
0.82%
3.18%
ROCE
1.24%
3.42%
EV
Common stock shares outstanding
298,653
299,535
Price
24.35
-26.77%
33.25
46.80%
Market cap
7,272,201
-26.98%
9,959,539
46.12%
EV
8,272,031
10,647,710
EBITDA
451,929
660,590
EV/EBITDA
18.30
16.12
Interest
59,538
41,883
Interest/NOPBT
43.25%
11.36%